首页> 外文期刊>Bioforum europe >Intercell Completed Its Public Offering
【24h】

Intercell Completed Its Public Offering

机译:Intercell完成了公开募股

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intercell has successfully completed its combined primary and secondary offering of its common stock.The offering consisted of a public offering in Austria and a private placement to institutional investors outside of Austria.The offer price was set at euro 12.36 per share,resulting in gross proceeds of euro 58.5 million to Intercell with 4,736,835 primary shares sold.Intercell intends to use the net proceeds of this offe ring for further organic growth of its promising vaccine pipeline,expansion of its ma nufacturing capacities and general corporate purposes.
机译:Intercell已成功完成其普通股的首次公开发行和二次发行,包括在奥地利公开发行和对奥地利以外的机构投资者进行的定向增发,发行价定为每股12.36欧元,总收益该公司向Intercell出售了5,850万欧元的股票,出售了4,736,835股主要股票。Intercell打算将这笔交易的净收益用于其有前途的疫苗产品线的进一步有机增长,扩大制造能力和一般公司用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号